Simone Ribero (S Ribero)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 148

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

Dermatologic therapy

Journal of clinical medicine

The British journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Gianluca Avallone, Francesco Cavallo, Annalisa Tancredi, Carlo Alberto Maronese, Martina Bertello, Alessandro Fraghì, Conforti Claudio, Giulia Calabrese, Matteo R Di Nicola, Giorgio A Oddenino, Luigi Gargiulo, Niccolò Gori, Camilla Loi, Paolo Romita, Viviana Piras, Laura Bonzano, Ersilia Tolino, Giovanni Paolino, Maddalena Napolitano, Cataldo Patruno, Eustachio Nettis, Caterina Ferreli, Gabriele Roccuzzo, Luca Marozio, Martina Silvio, Filomena Russo, Luca Bettolini, Rosella Gallo, Santo R Mercuri, Luca Mastorino, Mariateresa Rossi, Iris Zalaudek, Giuseppe Argenziano, Ilaria Trave, Antonio Costanzo, Andrea Chiricozzi, Carlotta Gurioli, Caterina Foti, Concetta Potenza, Silvia M Ferrucci, Anna Balato, Aurora Parodi, Angelo Valerio Marzano, Michela Ortoncelli, Simone Ribero, Pietro Quaglino
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Luigi Gargiulo, Luciano Ibba, F Piscazzi, F Amoruso, A Balato, Francesca Barei, Martina Bertello, A G Burroni, S Caccavale, S M Ferrucci, C Foti, Francesca Maria Gaiani, Giampiero Girolomoni, P Malagoli, Angelo Valerio Marzano, Martina Maurelli, Maddalena Napolitano, E Nettis, M Ortoncelli, C Patruno, E Pezzolo, Simone Ribero, P Romita, M T Rossi, I Zaza, M B Guanti, Antonio Costanzo, A Narcisi
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Gabriele Roccuzzo, Paolo Fava, Chiara Astrua, Matteo Giovanni Brizio, Giovanni Cavaliere, Eleonora Bongiovanni, Umberto Santaniello, Giulia Carpentieri, Luca Cangiolosi, Camilla Brondino, Valentina Pala, Simone Ribero, Pietro Quaglino
Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma. Cancers 16 (17) (2024)
Silvia Borriello, Sergio Delmonte, Tiziana Bisciari, Luca Mastorino, Simone Ribero, Pietro Quaglino
Secondary laryngeal and pulmonary syphilis: A case report. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (7) (2024)
Gianluca Avallone, Gabriele Roccuzzo, A Pileri, C Agostinelli, Carlo Alberto Maronese, C Aquino, Gianluca Tavoletti, F Onida, P Fava, Simone Ribero, Angelo Valerio Marzano, E Berti, Pietro Quaglino, S Alberti-Violetti
Clinicopathological definition, management and prognostic value of mogamulizumab-associated rash and other cutaneous events: A systematic review. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Niccolò Gori, Elena Ippoliti, Silvia Mariel Ferrucci, Anna Balato, Michela Ortoncelli, Martina Maurelli, Marco Galluzzo, Monica Munera Campos, Teofila Seremet, Lucia Di Nardo, Flaminia Antonelli, Giulia Coscarella, Curdin Conrad, Y José Manuel Carrascosa, Luca Bianchi, Giuseppe Argenziano, Simone Ribero, Giampiero Girolomoni, Angelo Valerio Marzano, Andrea Chiricozzi, Ketty Peris, null null
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Luca Mastorino, Paolo Dapavo, Caterina Cariti, Sara Susca, Niccolò Siliquini, Michela Ortoncelli, Elena Stroppiana, Anna Verrone, Isotta Giunipero di Corteranzo, Francesco Leo, Pietro Quaglino, Simone Ribero
Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience. Journal of personalized medicine 14 (7) (2024)
Gabriele Roccuzzo, Nicole Macagno, Pietro Grignani, Chiara Astrua, Matteo Giovanni Brizio, Giovanni Cavaliere, Franco Picciotto, Virginia Caliendo, Enrico Fruttero, Simone Ribero, Paolo Fava, Pietro Quaglino
Treatment Patterns and Outcomes of Stage III Melanoma Patients with Positive Sentinel Lymph Node Biopsy: A Real-Life Experience. Journal of clinical medicine 13 (17) (2024)
Gabriele Roccuzzo, Federica Repetto, Silvia Giordano, Cristina Sarda, Arianna Comes, Paolo Dapavo, Pietro Quaglino, Simone Ribero
Anti-IL17 Secukinumab in hidradenitis suppurativa: A long-term drug survival analysis. Experimental dermatology 33 (7) (2024)
Luigi Gargiulo, Luciano Ibba, F Piscazzi, F Amoruso, A Balato, Francesca Barei, Martina Bertello, A G Burroni, S Caccavale, S M Ferrucci, C Foti, Francesca Maria Gaiani, Giampiero Girolomoni, P Malagoli, Angelo Valerio Marzano, Martina Maurelli, Maddalena Napolitano, E Nettis, M Ortoncelli, C Patruno, E Pezzolo, Simone Ribero, P Romita, M T Rossi, I Zaza, M B Guanti, Antonio Costanzo, A Narcisi
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Nicole Macagno, Luca Mastorino, Niccolò Siliquini, Umberto Santaniello, Federica Gelato, Giovanni Cavaliere, Michela Ortoncelli, Simone Ribero, Pietro Quaglino
Safety of dupilumab in patients with cancer. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Antonio Tejera-Vaquerizo, Álvaro Gómez-Tomás, Ane Jaka, Agustín Toll, María Del Río, Carla Ferrándiz-Pulido, María J Fuente, Cristian Carrasco, Francisco M Almazán-Fernández, Tomás Toledo-Pastrana, Ada Ferrer-Fuertes, Simone Ribero, Gianluca Avallone, Javier Cañueto, Jorge Santos-Juanes, Onofre Sanmartín
Sentinel lymph node biopsy versus observation in high-risk cutaneous squamous cell carcinoma in immunosuppressed and immunocompetent patients: An inverse probability of treatment weighting study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2024)
Antonio Tejera-Vaquerizo, Álvaro Gómez-Tomás, Ane Jaka, Agustín Toll, María Del Río, Carla Ferrándiz-Pulido, María J Fuente, Cristian Carrasco, Francisco M Almazán-Fernández, Tomás Toledo-Pastrana, Ada Ferrer-Fuertes, Simone Ribero, Gianluca Avallone, Javier Cañueto, Jorge Santos-Juanes, Onofre Sanmartín
Sentinel lymph node biopsy versus observation in high-risk cutaneous squamous cell carcinoma in immunosuppressed and immunocompetent patients: An inverse probability of treatment weighting study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Gianluca Avallone, Francesco Cavallo, Annalisa Tancredi, Carlo Alberto Maronese, Martina Bertello, Alessandro Fraghì, Conforti Claudio, Giulia Calabrese, Matteo R Di Nicola, Giorgio A Oddenino, Luigi Gargiulo, Niccolò Gori, Camilla Loi, Paolo Romita, Viviana Piras, Laura Bonzano, Ersilia Tolino, Giovanni Paolino, Maddalena Napolitano, Cataldo Patruno, Eustachio Nettis, Caterina Ferreli, Gabriele Roccuzzo, Luca Marozio, Martina Silvio, Filomena Russo, Luca Bettolini, Rosella Gallo, Santo R Mercuri, Luca Mastorino, Mariateresa Rossi, Iris Zalaudek, Giuseppe Argenziano, Ilaria Trave, Antonio Costanzo, Andrea Chiricozzi, Carlotta Gurioli, Caterina Foti, Concetta Potenza, Silvia M Ferrucci, Anna Balato, Aurora Parodi, Angelo Valerio Marzano, Michela Ortoncelli, Simone Ribero, Pietro Quaglino
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Nicole Macagno, Luca Mastorino, Niccolò Siliquini, Umberto Santaniello, Federica Gelato, Giovanni Cavaliere, Michela Ortoncelli, Simone Ribero, Pietro Quaglino
Safety of dupilumab in patients with cancer. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Silvia Borriello, Sergio Delmonte, Tiziana Bisciari, Luca Mastorino, Simone Ribero, Pietro Quaglino
Secondary laryngeal and pulmonary syphilis: A case report. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (7) (2024)
Luca Mastorino, Paolo Dapavo, Caterina Cariti, Sara Susca, Niccolò Siliquini, Michela Ortoncelli, Elena Stroppiana, Anna Verrone, Isotta Giunipero di Corteranzo, Francesco Leo, Pietro Quaglino, Simone Ribero
Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience. Journal of personalized medicine 14 (7) (2024)
Elena Pezzolo, Michela Ortoncelli, Silvia Mariel Ferrucci, Mario Bruno Guanti, Donatella Schena, Maddalena Napolitano, Mariateresa Rossi, Caterina Foti, Domenico D'Amico, Giuseppe Fabrizio Amoruso, Pietro Morrone, Simone Ribero, Francesca Barei, Matteo Biagi, Enrico Pascucci, Cataldo Patruno, Piergiacomo Calzavara-Pinton, Paolo Romita, Luigi Gargiulo, Alessandra Narcisi, Luigi Naldi
Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter Analysis. Journal of clinical medicine 13 (2) (2024)
Silvia Borriello, Sergio Delmonte, Tiziana Bisciari, Luca Mastorino, Simone Ribero, Pietro Quaglino
Secondary laryngeal and pulmonary syphilis: A case report. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Elena Pezzolo, Michela Ortoncelli, Silvia Mariel Ferrucci, Mario Bruno Guanti, Donatella Schena, Maddalena Napolitano, Mariateresa Rossi, Caterina Foti, Domenico D'Amico, Giuseppe Fabrizio Amoruso, Pietro Morrone, Simone Ribero, Francesca Barei, Matteo Biagi, Enrico Pascucci, Cataldo Patruno, Piergiacomo Calzavara-Pinton, Paolo Romita, Luigi Gargiulo, Alessandra Narcisi, Luigi Naldi
Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter Analysis. Journal of clinical medicine 13 (2) (2024)
Gianluca Avallone, Gabriele Roccuzzo, A Pileri, C Agostinelli, Carlo Alberto Maronese, C Aquino, Gianluca Tavoletti, F Onida, P Fava, Simone Ribero, Angelo Valerio Marzano, E Berti, Pietro Quaglino, S Alberti-Violetti
Clinicopathological definition, management and prognostic value of mogamulizumab-associated rash and other cutaneous events: A systematic review. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Bianca Maria Piraccini, Francesca Pampaloni, Stephano Cedirian, F Quadrelli, Francesca Bruni, Luca Rapparini, Gemma Caro, M C Acri, L Ala, Alfredo Rossi, G Pellacani, Francesco Lacarrubba, G Micali, F Dall'Oglio, Marina Vastarella, M Cantelli, P Nappa, Laura Diluvio, L Bianchi, Laura Gnesotto, Andrea Sechi, L Naldi, F Tassone, K Peris, Giacomo Caldarola, L M Pinto, Giampiero Girolomoni, F Marangoni, Francesco Bellinato, Paolo Gisondi, I Scandagli, Francesca Prignano, N Pimpinelli, C Tomasini, Stefania Barruscotti, Edoardo De Simoni, O Simonetti, F Ambrogio, C Foti, V Boccaletti, A Fraghì, Angelo Valerio Marzano, M A Mattioli, L Rocca, M Barbareschi, S M Ferrucci, Giuseppe Gallo, Simone Ribero, Pietro Quaglino, R Balestri, T Ioris, R D Caposiena Caro, I Zalaudek, E Vagnozzi, Maria-Concetta Fargnoli, C Caponio, P Rubegni, Elisa Cinotti, Emanuele Trovato, M Romanelli, Valentina Dini, Flavia Manzo Margiotta, Claudio Feliciani, M B de Felici Del Giudice, Laura Atzori, S Sanna, S Lembo, Annunziata Raimondo, Michela Magnano, Michela Valeria Rita Starace
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Luigi Gargiulo, Luciano Ibba, F Piscazzi, F Amoruso, A Balato, Francesca Barei, Martina Bertello, A G Burroni, S Caccavale, S M Ferrucci, C Foti, Francesca Maria Gaiani, Giampiero Girolomoni, P Malagoli, Angelo Valerio Marzano, Martina Maurelli, Maddalena Napolitano, E Nettis, M Ortoncelli, C Patruno, E Pezzolo, Simone Ribero, P Romita, M T Rossi, I Zaza, Antonio Costanzo, A Narcisi
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Luca Mastorino, Paolo Dapavo, Caterina Cariti, Sara Susca, Niccolò Siliquini, Michela Ortoncelli, Elena Stroppiana, Anna Verrone, Isotta Giunipero di Corteranzo, Francesco Leo, Pietro Quaglino, Simone Ribero
Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience. Journal of personalized medicine 14 (7) (2024)
Gianluca Avallone, Francesco Cavallo, Annalisa Tancredi, Carlo Alberto Maronese, Martina Bertello, Alessandro Fraghì, Conforti Claudio, Giulia Calabrese, Matteo R Di Nicola, Giorgio A Oddenino, Luigi Gargiulo, Niccolò Gori, Camilla Loi, Paolo Romita, Viviana Piras, Laura Bonzano, Ersilia Tolino, Giovanni Paolino, Maddalena Napolitano, Cataldo Patruno, Eustachio Nettis, Caterina Ferreli, Gabriele Roccuzzo, Luca Marozio, Martina Silvio, Filomena Russo, Luca Bettolini, Rosella Gallo, Santo R Mercuri, Luca Mastorino, Mariateresa Rossi, Iris Zalaudek, Giuseppe Argenziano, Ilaria Trave, Antonio Costanzo, Andrea Chiricozzi, Carlotta Gurioli, Caterina Foti, Concetta Potenza, Silvia M Ferrucci, Anna Balato, Aurora Parodi, Angelo Valerio Marzano, Michela Ortoncelli, Simone Ribero, Pietro Quaglino
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Antonio Tejera-Vaquerizo, Álvaro Gómez-Tomás, Ane Jaka, Agustín Toll, María Del Río, Carla Ferrándiz-Pulido, María J Fuente, Cristian Carrasco, Francisco M Almazán-Fernández, Tomás Toledo-Pastrana, Ada Ferrer-Fuertes, Simone Ribero, Gianluca Avallone, Javier Cañueto, Jorge Santos-Juanes, Onofre Sanmartín
Sentinel lymph node biopsy versus observation in high-risk cutaneous squamous cell carcinoma in immunosuppressed and immunocompetent patients: An inverse probability of treatment weighting study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2024)
Gianluca Avallone, Gabriele Roccuzzo, A Pileri, C Agostinelli, Carlo Alberto Maronese, C Aquino, Gianluca Tavoletti, F Onida, P Fava, Simone Ribero, Angelo Valerio Marzano, E Berti, Pietro Quaglino, S Alberti-Violetti
Clinicopathological definition, management and prognostic value of mogamulizumab-associated rash and other cutaneous events: A systematic review. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Luca Mastorino, F Gelato, P Quaglino, M Ortoncelli, Simone Ribero
Efficacy of tralokinumab after failure with upadacitinib and dupilumab in a patient affected by atopic dermatitis. The Journal of dermatological treatment 34 (1) (2023)
Luca Mastorino, Federica Gelato, Irene Richiardi, Giovanni Cavaliere, Pietro Quaglino, Michela Ortoncelli, Simone Ribero
Dose reduction of dupilumab in atopic patients with controlled atopic dermatitis: A safe and effective practice? Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Luca Mastorino, P Dapavo, Lorenza Burzi, F Rosset, I Giunipero di Corteranzo, F Leo, A Verrone, E Stroppiana, M Ortoncelli, Simone Ribero, Pietro Quaglino
Drug survival, effectiveness and safety of ixekizumab for moderate-to-severe psoriasis up to 5 years. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (3) (2023)
Roberto Patuzzo, Ilaria Mattavelli, Gianfranco Gallino, Carlotta Galeone, Barbara Valeri, Simone Mocellin, Paolo Del Fiore, Simone Ribero, Mario Mandalà, Francesca Tauceri, Maurizio Lombardo, Andrea Maurichi, null null
The prognostic role of mitotic rate in cutaneous malignant melanoma: Evidence from a multicenter study on behalf of the Italian Melanoma Intergroup. Cancer (2023)
Francois Rosset, Luca Mastorino, P Dapavo, Pietro Quaglino, Simone Ribero
Impact of comorbidities in elderly and frail patients and response to biological therapy in psoriasis. Experimental dermatology (2023)
Alessia Andrea Ricci, Paolo Dapavo, Luca Mastorino, Gabriele Roccuzzo, Samanta Wolff, Simone Ribero, Paola Cassoni, Rebecca Senetta, Pietro Quaglino
Exploring Psoriasis Inflammatory Microenvironment by NanoString Technologies. Journal of clinical medicine 12 (21) (2023)
Gianluca Tavoletti, Gianluca Avallone, Conforti Claudio, G Roccuzzo, Carlo Alberto Maronese, M A Mattioli, Pietro Quaglino, I Zalaudek, Angelo Valerio Marzano, Simone Ribero, S Alberti-Violetti
Topical Ruxolitinib: A new treatment for vitiligo. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Luca Mastorino, F Gelato, P Quaglino, M Ortoncelli, Simone Ribero
Efficacy of tralokinumab after failure with upadacitinib and dupilumab in a patient affected by atopic dermatitis. The Journal of dermatological treatment 34 (1) (2023)
Gianluca Avallone, Carlo Alberto Maronese, Giulia Murgia, Carlo Giovanni Carrera, Luca Mastorino, Gabriele Roccuzzo, Paolo Dapavo, Silvia Alberti Violetti, Pietro Quaglino, Simone Ribero, Angelo Valerio Marzano
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study. Journal of clinical medicine 12 (4) (2023)
Luca Mastorino, P Dapavo, Lorenza Burzi, F Rosset, I Giunipero di Corteranzo, F Leo, A Verrone, E Stroppiana, M Ortoncelli, Simone Ribero, Pietro Quaglino
Drug survival, effectiveness and safety of ixekizumab for moderate-to-severe psoriasis up to 5 years. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Mario Mandalà, Giuseppe Palmieri, Vienna Ludovini, Sara Baglivo, Francesca Marasciulo, Francesca Castiglione, Alessio Gili, Simona Osella Abate, Marco Rubatto, Rebecca Senetta, Gianluca Avallone, Simone Ribero, Luca Romano, Nicola Pimpinelli, Vincenzo De Giorgi, Fausto Roila, Marina Pisano, Milena Casula, Antonella Manca, Maria Cristina Sini, Daniela Massi, Pietro Quaglino, null null
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Francois Rosset, Luca Mastorino, Paolo Dapavo, Michela Ortoncelli, Pietro Quaglino, Simone Ribero
Aging Impact in Response to Different Classes of Biological Treatment in Psoriatic Patients: A Real-Life Observational Study. Journal of clinical medicine 12 (23) (2023)
Nadia Sciamarrelli, Niccolò Siliquini, Luca Mastorino, Rebecca Senetta, Paolo Dapavo, Simone Ribero, Pietro Quaglino
Exacerbation of acquired perforating dermatosis following SARS-CoV-2 vaccination. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Marco Rubatto, Franco Picciotto, Giovenale Moirano, Enrico Fruttero, Virginia Caliendo, Silvia Borriello, Nadia Sciamarrelli, Paolo Fava, Rebecca Senetta, Adriana Lesca, Anna Sapino, Desiree' Deandreis, Simone Ribero, Pietro Quaglino
Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience. Journal of clinical medicine 12 (2) (2023)
Luca Mastorino, F Gelato, I Richiardi, G Cavaliere, Pietro Quaglino, M Ortoncelli, Simone Ribero
Dose reduction of dupilumab in atopic patients with controlled atopic dermatitis: a safe and effective practice? Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Nadia Sciamarrelli, Niccolò Siliquini, Luca Mastorino, Rebecca Senetta, Paolo Dapavo, Simone Ribero, Pietro Quaglino
Exacerbation of Acquired Perforating Dermatosis Following SARS-CoV-2 Vaccination. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Luca Mastorino, M Ortoncelli, P Dapavo, Simone Ribero, Pietro Quaglino
'Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients'-response to Yu et al. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Federica Gelato, Luca Mastorino, Ekaterina Stepkina, Giovanni Cavaliere, Simone Ribero, Pietro Quaglino, Michela Ortoncelli
Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis? Journal of clinical medicine 12 (6) (2023)
Federica Gelato, Luca Mastorino, Ekaterina Stepkina, Giovanni Cavaliere, Simone Ribero, Pietro Quaglino, Michela Ortoncelli
Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis? Journal of clinical medicine 12 (6) (2023)
Marco Miniotti, Simone Ribero, Luca Mastorino, Michela Ortoncelli, Federica Gelato, Mariagiulia Bailon, Jacopo Trioni, Beatrice Stefan, Pietro Quaglino, Paolo Leombruni
Long-term psychological outcome of patients with moderate-to-severe atopic dermatitis continuously treated with Dupilumab: data up to three years. Experimental dermatology (2023)
Gabriele Roccuzzo, Silvia Giordano, Thomas Granato, Francesco Cavallo, Luca Mastorino, Gianluca Avallone, Barbara Pasini, Pietro Quaglino, Simone Ribero
Phenotypic and Dermoscopic Patterns of Familial Melanocytic Lesions: A Pilot Study in a Third-Level Center. Cancers 15 (15) (2023)
Silvia Giordano, Paolo Dapavo, Michela Ortoncelli, Elena Stroppiana, Anna Verrone, Pietro Quaglino, Simone Ribero, Luca Mastorino
Interclass Switch between IL17 and IL23 Inhibitors in Psoriasis: A Real-Life, Long-Term, Single-Center Experience. Journal of clinical medicine 12 (24) (2023)
Marco Miniotti, Simone Ribero, Luca Mastorino, Michela Ortoncelli, Federica Gelato, Mariagiulia Bailon, Jacopo Trioni, Beatrice Stefan, Pietro Quaglino, Paolo Leombruni
Long-term psychological outcome of patients with moderate-to-severe atopic dermatitis continuously treated with Dupilumab: Data up to 3 years. Experimental dermatology (2023)
Luca Mastorino, P Dapavo, Lorenza Burzi, F Rosset, I Giunipero di Corteranzo, F Leo, A Verrone, E Stroppiana, M Ortoncelli, Simone Ribero, Pietro Quaglino
Drug survival, effectiveness and safety of ixekizumab for moderate-to-severe psoriasis up to 5 years. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (3) (2023)
Marco Rubatto, Franco Picciotto, Giovenale Moirano, Enrico Fruttero, Virginia Caliendo, Silvia Borriello, Nadia Sciamarrelli, Paolo Fava, Rebecca Senetta, Adriana Lesca, Anna Sapino, Desiree' Deandreis, Simone Ribero, Pietro Quaglino
Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience. Journal of clinical medicine 12 (2) (2023)
Gianluca Avallone, Carlo Alberto Maronese, Giulia Murgia, Carlo Giovanni Carrera, Luca Mastorino, Gabriele Roccuzzo, Paolo Dapavo, Silvia Alberti Violetti, Pietro Quaglino, Simone Ribero, Angelo Valerio Marzano
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study. Journal of clinical medicine 12 (4) (2023)
Gianluca Tavoletti, Gianluca Avallone, Conforti Claudio, G Roccuzzo, Carlo Alberto Maronese, M A Mattioli, Pietro Quaglino, I Zalaudek, Angelo Valerio Marzano, Simone Ribero, Silvia Alberti Violetti
Topical ruxolitinib: A new treatment for vitiligo. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Gianluca Avallone, Carlo Alberto Maronese, Giulia Murgia, Carlo Giovanni Carrera, Luca Mastorino, Gabriele Roccuzzo, Paolo Dapavo, Silvia Alberti Violetti, Pietro Quaglino, Simone Ribero, Angelo Valerio Marzano
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study. Journal of clinical medicine 12 (4) (2023)
Luca Mastorino, Caterina Cariti, Sara Susca, Niccolò Siliquini, Anna Verrone, Elena Stroppiana, Michela Ortoncelli, Paolo Dapavo, Pietro Quaglino, Simone Ribero
Comparison between brodalumab, secukinumab and ixekizumab effectiveness and drug survival: A real-life experience on 638 patients with psoriasis. Experimental dermatology (2023)
Luca Mastorino, S Susca, C Cariti, Niccolò Siliquini, A Verrone, E Stroppiana, M Ortoncelli, P Dapavo, Simone Ribero, Pietro Quaglino
Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Federica Gelato, Luca Mastorino, Ekaterina Stepkina, Giovanni Cavaliere, Simone Ribero, Pietro Quaglino, Michela Ortoncelli
Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis? Journal of clinical medicine 12 (6) (2023)
Emmanouil Chousakos, Daniela Zugna, Emi Dika, Aram Boada, Sebastian Podlipnik, Cristina Carrera, Josep Malvehy, Susana Puig, Celia Requena, Esperanza Manrique-Silva, Eduardo Nagore, Pietro Quaglino, Rebecca Senetta, Simone Ribero
Topographical and Chronological Analysis of Thin Cutaneous Melanoma's Progressions: A Multicentric Study. Cancers 15 (15) (2023)
Simone Ribero, Pietro Quaglino, Gabriele Roccuzzo
Collaborative efforts in studying Mediterranean melanoma families: A step towards precision medicine. Journal of the European Academy of Dermatology and Venereology : JEADV 37 (12) (2023)
Silvia Giordano, Paolo Dapavo, Michela Ortoncelli, Elena Stroppiana, Anna Verrone, Pietro Quaglino, Simone Ribero, Luca Mastorino
Interclass Switch between IL17 and IL23 Inhibitors in Psoriasis: A Real-Life, Long-Term, Single-Center Experience. Journal of clinical medicine 12 (24) (2023)
Marco Rubatto, Franco Picciotto, Giovenale Moirano, Enrico Fruttero, Virginia Caliendo, Silvia Borriello, Nadia Sciamarrelli, Paolo Fava, Rebecca Senetta, Adriana Lesca, Anna Sapino, Desiree' Deandreis, Simone Ribero, Pietro Quaglino
Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience. Journal of clinical medicine 12 (2) (2023)
Valentina Pala, Simone Ribero, Pietro Quaglino, Luca Mastorino
Updates on Potential Therapeutic Approaches for Vitiligo: Janus Kinase Inhibitors and Biologics. Journal of clinical medicine 12 (23) (2023)
Marco Rubatto, Franco Picciotto, Giovenale Moirano, Enrico Fruttero, Virginia Caliendo, Silvia Borriello, Nadia Sciamarrelli, Paolo Fava, Rebecca Senetta, Adriana Lesca, Anna Sapino, Desiree' Deandreis, Simone Ribero, Pietro Quaglino
Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience. Journal of clinical medicine 12 (2) (2023)
Gianluca Avallone, Carlo Alberto Maronese, Giulia Murgia, Carlo Giovanni Carrera, Luca Mastorino, Gabriele Roccuzzo, Paolo Dapavo, Silvia Alberti Violetti, Pietro Quaglino, Simone Ribero, Angelo Valerio Marzano
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study. Journal of clinical medicine 12 (4) (2023)
Carlo Alberto Maronese, Stefano Ramoni, Gianluca Avallone, Serena Giacalone, Eleonora Quattri, Valeria Gaspari, Luca Rapparini, Silvia Robuffo, Sergio Delmonte, Martina Merli, Marco Tutone, Giulia Facci, Andrea Carugno, Michele Parietti, Alessandra Latini, Eugenia Giuliani, Paolo Sena, Simone Ribero, Pietro Quaglino, Bianca Maria Piraccini, Angelo Valerio Marzano
Monkeypox: an Italian, multicenter study of 104 cases. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Marco Rubatto, Franco Picciotto, Giovenale Moirano, Enrico Fruttero, Virginia Caliendo, Silvia Borriello, Nadia Sciamarrelli, Paolo Fava, Rebecca Senetta, Adriana Lesca, Anna Sapino, Desiree' Deandreis, Simone Ribero, Pietro Quaglino
Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience. Journal of clinical medicine 12 (2) (2023)
Luca Mastorino, S Susca, C Cariti, N Sliquini, A Verrone, E Stroppiana, M Ortoncelli, P Dapavo, Simone Ribero, Pietro Quaglino
Efficacy of anti IL23 and anti IL17 after adalimumab failure in psoriatic patients. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Luca Mastorino, Gabriele Roccuzzo, Paolo Dapavo, Niccolò Siliquini, Gianluca Avallone, Marco Rubatto, Pietro Quaglino, Simone Ribero
Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice? Dermatologic therapy 35 (9) (2022)
Marco Miniotti, Giulia Lazzarin, Michela Ortoncelli, Luca Mastorino, Simone Ribero, Paolo Leombruni
Impact on health-related quality of life and symptoms of anxiety and depression after 32 weeks of Dupilumab treatment for moderate-to-severe atopic dermatitis. Dermatologic therapy 35 (5) (2022)
Marco Rubatto, Nicole Macagno, Ginevra Pastorin, Paolo Fava, Luca Ceroni, Simone Ribero, Pietro Quaglino
Liver metastases and immunotherapy: A barrier to response for metastatic melanoma. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Giuseppe Gallo, Lorenza Burzi, Francesca Torrelli, Pietro Quaglino, Simone Ribero
Low-dose oral minoxidil in female patients with lichen planopilaris: Real-life experience. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Gabriele Roccuzzo, Francesco Cavallo, Gianluca Avallone, Paolo Fava, Luca Conti, Simone Ribero, Maria Teresa Fierro, Pietro Quaglino
Guttate psoriasis in a patient with mycosis fungoides in treatment with Brentuximab vedotin: An unreported association. Dermatologic therapy 35 (4) (2022)
Luca Mastorino, Gabriele Roccuzzo, Paolo Dapavo, Niccolò Siliquini, Gianluca Avallone, Marco Rubatto, Martina Merli, Andrea Agostini, Simone Ribero, Pietro Quaglino
Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population. The British journal of dermatology 187 (2) (2022)
Gabriele Roccuzzo, Paolo Fava, Gianluca Avallone, Carola Aquino, Sara Boskovic, Nicole Macagno, Simone Ribero, Pietro Quaglino
Time to next treatment and safety assessment in cutaneous-T-cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin. The British journal of dermatology 187 (6) (2022)
Giuseppe Gallo, Luca Mastorino, Luca Tonella, Simone Ribero, Pietro Quaglino
Alopecia areata after COVID-19 vaccination. Clinical and experimental vaccine research 11 (1) (2022)
Gabriele Roccuzzo, Giulia Rozzo, Lorenza Burzi, Federica Repetto, Paolo Dapavo, Simone Ribero, Pietro Quaglino
Switching from adalimumab originator to biosimilars in hidradenitis suppurativa: What's beyond cost-effectiveness? Dermatologic therapy 35 (11) (2022)
Giuseppe Gallo, Luca Mastorino, Diego Barilà, Francesco Cattel, Michele Panzone, Pietro Quaglino, Simone Ribero, Paolo Dapavo
Topical cyclosporine hydrogel preparation: A new therapeutic option in the treatment of nail psoriasis. Dermatologic therapy (2022)
Luca Mastorino, C Cariti, S Susca, S Boskovic, C Aquino, M Ortoncelli, E Stroppiana, A Verrone, P Dapavo, P Quaglino, Simone Ribero
Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks. The Journal of dermatological treatment (2022)
Luca Mastorino, V L Cantafio Duò, C Vecco, F Gelato, S Giordano, G Roccuzzo, G Cavaliere, G Avallone, M Ortoncelli, Simone Ribero, Pietro Quaglino
Impact of comorbidities in the response of atopic patients treated with dupilumab: a real-life study up to 36 weeks. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (12) (2022)
Luca Mastorino, F Castelli, E Stroppiana, A Verrone, M Ortoncelli, S Susca, S Boskovic, S G Passerini, Nicole Macagno, C Cariti, M Licciardello, C Solaroli, G Pertusi, M G Aragone, G Baggini, C Addese, C Leporati, R Peila, M T Giura, G Rossotto, P Pella, L Mocci, G Merlo, R Tiberio, F Graziola, Pietro Quaglino, P Dapavo, Simone Ribero
Risankizumab shows faster response in bio naïve than in bio-experienced psoriatic patients. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (10) (2022)
Luca Mastorino, Caterina Cariti, Sara Susca, Nadia Sciamarrelli, Silvia Borriello, Michela Ortoncelli, Elena Stroppiana, Anna Verrone, Paolo Dapavo, Pietro Quaglino, Simone Ribero
Tildrakizumab in real-life shows good efficacy in moderate-to-severe psoriasis regardless of previous use of biologic drugs and joint involvement. Dermatologic therapy 35 (11) (2022)
Luca Mastorino, Sara Susca, Matteo Megna, Niccolò Siliquini, Pietro Quaglino, Michela Ortoncelli, Gianluca Avallone, Marco Rubatto, Gabriella Fabbrocini, Paolo Dapavo, Simone Ribero
Risankizumab shows high efficacy and maintenance in improvement of response until week 52. Dermatologic therapy 35 (5) (2022)
Pietro Quaglino, Mauro Novelli, Paolo Fava, Erika Ortolan, Chiara Astrua, Luca Tonella, Carlo Francesco Tomasini, Rebecca Senetta, Simone Ribero, Renata Ponti, Maria Teresa Fierro, Ada Funaro
CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study. Disease markers 2022 (2022)
Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Mattia Zenone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
Guselkumab shows high efficacy and maintenance in the improvement of response until week 48, a real-life study. Dermatologic therapy 35 (10) (2022)
Luca Mastorino, S Susca, C Cariti, A Verrone, E Stroppiana, M Ortoncelli, P Dapavo, Simone Ribero, Pietro Quaglino
"Superresponders" at biologic treatment for psoriasis: a comparative study among IL17 and Il23 inhibitors. Experimental dermatology (2022)
Gianluca Avallone, C Cariti, P Dapavo, M Ortoncelli, L Conforto, Luca Mastorino, Gabriele Roccuzzo, Francesco Cavallo, Marco Rubatto, Pietro Quaglino, Simone Ribero
Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (7) (2022)
Francesco Cavallo, Gabriele Roccuzzo, Gianluca Avallone, Conforti Claudio, Iris Zalaudek, Silvia Giordano, Marco Rubatto, Paolo Fava, Simone Ribero, Pietro Quaglino
Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome? Dermatologic therapy 35 (7) (2022)
Nicole Macagno, Luca Mastorino, Marco Rubatto, G Avallone, M Merli, Andrea Agostini, P Fava, Simone Ribero, Pietro Quaglino
Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: A single-centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (12) (2022)
Gianluca Avallone, Francesco Cavallo, C Astrua, Giacomo Caldarola, Conforti Claudio, C De Simone, N di Meo, A di Stefani, Giovanni Genovese, Carlo Alberto Maronese, Angelo Valerio Marzano, R Parente, Pietro Quaglino, G Roccuzzo, F Tassone, I Zalaudek, R Senetta, Simone Ribero
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (11) (2022)
Federica Gelato, Luca Mastorino, Paola Cavalla, Pietro Quaglino, Giovanni Cavaliere, Marco Vercellino, Chiara Bosa, Matilde Inglese, Raffaele De Palma, Michela Ortoncelli, Simone Ribero
Onset of multiple sclerosis in a patient on dupilumab therapy for atopic dermatitis: A case report. Dermatologic therapy 35 (10) (2022)
Gianluca Avallone, Carlo Alberto Maronese, Eleonora Quattri, Gabriele Roccuzzo, Luca Mastorino, Silvia Alberti-Violetti, Stefano Ramoni, Anna Lucchini, Sergio Delmonte, Pietro Quaglino, Angelo Valerio Marzano, Simone Ribero
Maculopapular rash: An overlooked monkeypox diagnostic clue? Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Gianluca Avallone, S Giordano, C Astrua, M Merli, R Senetta, Conforti Claudio, Simone Ribero, Angelo Valerio Marzano, Pietro Quaglino
Reply to 'The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?' by Damiani G et al. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (6) (2022)
Gianluca Avallone, Martina Merli, Carmen Dell'Aquila, Pietro Quaglino, Simone Ribero, Iris Zalaudek, Conforti Claudio
Imiquimod-side effects in the treatment of periocular skin cancers: A review of the literature. Dermatologic therapy 35 (4) (2022)
Giulia Gullo, Marco Rubatto, Paolo Fava, Matteo Brizio, Luca Tonella, Simone Ribero, Matelda Medri, Gianluca Avallone, Luca Mastorino, Maria Teresa Fierro, Ignazio Stanganelli, Pietro Quaglino
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study. Dermatologic therapy 35 (6) (2022)
Lorenza Burzi, Federica Repetto, Simone Ribero, Luca Mastorino, Pietro Quaglino, Paolo Dapavo
Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real-life experience and therapeutic response to other biological drugs. Dermatologic therapy (2022)
Luca Mastorino, Sara Susca, Caterina Cariti, Anna Verrone, Elena Stroppiana, Michela Ortoncelli, Paolo Dapavo, Simone Ribero, Pietro Quaglino
"Superresponders" at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors. Experimental dermatology (2022)
Gabriele Roccuzzo, Tommaso Tibaldi, Francesco Cavallo, Carola Aquino, Teresa Rolle, Pietro Quaglino, Simone Ribero
Retinoid-associated myopia in dermatologic patients: a systematic review. Cutaneous and ocular toxicology 41 (4) (2022)
Gianluca Avallone, Carlo Alberto Maronese, Conforti Claudio, Paolo Fava, Luigi Gargiulo, Angelo Valerio Marzano, C Massone, Luca Mastorino, Andrea Paradisi, A Pileri, Pietro Quaglino, N Rizzo, Simone Ribero, G Roccuzzo, G Tavoletti, C A Vignoli, I Zalaudek, E Berti, S Alberti-Violetti
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: a multicentre experience from tertiary referral hospitals. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Michele Parietti, Lorenza Burzi, Simone Ribero, Giuseppe Gallo, Federica Repetto, Paolo Dapavo
Persistent eruptive lentiginosis in a psoriatic patient after 4-year effective treatment with ustekinumab. Dermatologic therapy 35 (6) (2022)

Simone Ribero.css-eqlu8i{font-size:small;padding-left:4px;} (S Ribero)

Publication Activity (10 Years)

Top Topics

Top Venues

Simone Ribero (S Ribero)